Company / CIK 0001681682
ENDRA Life Sciences Inc.
- Ticker
- NDRA
- Size, estimated from filings
- Micro cap (under $300M)
- Insiders on file
- 6
- Federal contracts on record
- none matched
- Lobbying filings on record
- none matched
- SEC filings
- EDGAR ↗
- Latest trade on record
- March 2, 2026
ENDRA Life Sciences Inc. (NDRA) has 6 insiders on file who disclosed 7 transactions in the last 12 months (0 open-market buys, 0 sales, about $0 at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| UBS Group AG | Insider | 1 | 1 | 0 | May 29, 2026 |
| Tokman Alexander Y | Chief Executive Officer | 2 | 0 | 0 | March 4, 2026 |
| Jacroux Richard | Chief Financial Officer | 2 | 0 | 0 | March 4, 2026 |
| DIGIANDOMENICO ANTHONY | Director | 3 | 0 | 0 | January 23, 2026 |
| Harsh Michael | Director | 2 | 0 | 0 | January 23, 2026 |
| Basenese Lou | Director | 2 | 0 | 0 | January 23, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jacroux Richard | NDRA | Other A | March 2, 2026 | March 4, 2026 | 2d | 13,461 | — | — | Form 4 ↗ | ||
| Tokman Alexander Y | NDRA | Other A | March 2, 2026 | March 4, 2026 | 2d | 26,921 | — | — | Form 4 ↗ | ||
| Tokman Alexander Y | NDRA | Other A | January 21, 2026 | January 23, 2026 | 2d | 75,000 | — | — | Form 4 ↗ | ||
| Basenese Lou | NDRA | Other A | January 21, 2026 | January 23, 2026 | 2d | 60,324 | — | — | Form 4 ↗ | ||
| Jacroux Richard | NDRA | Other A | January 21, 2026 | January 23, 2026 | 2d | 20,000 | — | — | Form 4 ↗ | ||
| Harsh Michael | NDRA | Other A | January 21, 2026 | January 23, 2026 | 2d | 60,324 | — | — | Form 4 ↗ | ||
| DIGIANDOMENICO ANTHONY | NDRA | Other A | January 21, 2026 | January 23, 2026 | 2d | 60,324 | — | — | Form 4 ↗ | ||
| DIGIANDOMENICO ANTHONY | NDRA | Other A | October 10, 2025 | October 15, 2025 | 5d | 141,644 | $0 | $7 | latederivative | Form 4 ↗ | |
| DIGIANDOMENICO ANTHONY | NDRA | Other A | October 10, 2025 | October 15, 2025 | 5d | 70,822 | $7 | $500K | late | Form 4 ↗ | |
| Harsh Michael | NDRA | Other A | June 11, 2025 | July 1, 2025 | 20d | 5,384 | — | — | late | Form 4 ↗ | |
| Basenese Lou | NDRA | Other A | June 11, 2025 | July 1, 2025 | 20d | 5,384 | — | — | late | Form 4 ↗ | |
| UBS Group AG | NDRA | Buy P | August 27, 2024 | August 29, 2024 | 2d | 3,715 | $1 | $2,052 | indirect | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "ENDRA Life Sciences Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
No LDA filing posted since October 2025 names "ENDRA Life Sciences Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.
Related companies
Companies whose stock was traded by the same people who traded NDRA, by number of filers in common. It shows overlap in public filings and nothing else.
- PIMCO CALIFORNIA MUNICIPAL INCOME FUND PCQ 1 filer in common
- Volcon, Inc. VLCN 1 filer in common
- GABELLI EQUITY TRUST INC GAB 1 filer in common
- GABELLI DIVIDEND & INCOME TRUST GDV 1 filer in common
- EATON VANCE SENIOR FLOATING RATE TRUST EFR 1 filer in common
- PIMCO NEW YORK MUNICIPAL INCOME FUND II PNI 1 filer in common
- GABELLI MULTIMEDIA TRUST INC. GGT 1 filer in common
- EATON VANCE LTD DURATION INCOME FUND EVV 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 11 | 12 | August 29, 2024 | March 4, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.